Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission: Results and prognostic factors in 326 consecutive patients

Strahlentherapie und Onkologie

Volumn 174, Issue 2, 1998, Pages 92-104

  Belkacemi Y ^a   Pene F ^a   Touboul, E ^a   Rio, B ^b   Leblond, V ^c   Gorin, N C ^d   Laugier, A ^a   Gemici, C ^a   Housset, M ^a   Ozsahin, M ^a,e  

^a HÔPITAL TENON   (France)

^b HÔTEL DIEU   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Acute leukemia; BMT; Dose rate; Fractionation; TBI

Indexed keywords

CYCLOPHOSPHAMIDE; HEPARIN; METHOTREXATE; PENTIFYLLINE; PROSTAGLANDIN E2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW RESCUE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; SURVIVAL TIME; TREATMENT OUTCOME; VEIN OCCLUSION; WHOLE BODY RADIATION;

EID: 6844266279     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03038482     Document Type: Article

References (66)

1. Appelbaum F, L Fisher, ED Thomas. Chemotherapy vs. marrow transplantation for adults with acute nonlymphoblastic leukemia: a five-year follow-up. Blood 1988;72:179-84.
2. Baranov AE, GD Selidovkin, A Butturini et al. Hematopoietic recovery after 10-Gy acute total body irradiation. Blood 1994;83:596-9.
3. Barrett A. Total body irradiation (TBI) before bone marrow transplantation in leukemia: a co-operative study from the European Group for Bone Marrow Transplantation. Br J Radiol 1982;55:562-7.
4. Barrett A, MH Depledge, RL Powles. Interstitial pneumonias following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys 1983;9:1029-33.
5. Barrett A, J Nicholls, B Gibson. Late effects of total body irradiation. Radiother Oncol 1987;9:131-5.
6. Baume D, JM Cosset, JL Pico et al. Maladie veino-occlusive du foie après greffe de moelle osseuse: intérêt possible du fractionnement de l'irradiation corporelle totale. Presse Méd 1987;16:1759.
7. Belkacémi Y, M Ozsahin, F Pène et al. Cataractogenesis after total-body irradiation. Int J Radiat Oncol Biol Phys 1996;10:53-60.
8. Belkacémi Y, M Ozsahin, B Rio et al. Is veno-occlusive disease influenced by the total-body irradiation technique. Strahlenther Onkol 1995; 171:694-7.
9. Brauner R, M Fontoura, JM Zucker et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993; 68:458-63.
10. Brochstein JA, NA Kernan, S Groshen et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987; 317:1618-24.
11. Calissendorff BM, P Bolme. Cataract development and outcome of surgery in bone marrow transplanted children. Br J Ophthalmol 1993;77:36-8.
12. Chalmers EA, AM Sproul, KI Mills et al. Effect of radiation dose on the development of mixed haemopoietic chimerism following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1992;10:425-30.
13. Clift RA, CD Buckner, FR Appelbaum et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood 1991;77:1660-65.
14. Cordonnier C, JF Bernaudin, P Bierling et al. Pulmonary complications occurring after allogeneic bone marrow transplantation: a study of 130 consecutive transplanted patients. Cancer 1986;58:1047-54.
15. Cosset JM, D Baume, JL Pico et al. Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a non-randomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol 1989;15:151-60.
16. Cox D. R. Regression models and life tables. J R Stat Soc 1972;34: 187-220.
17. Deeg HJ. Interstitial pneumonitis. In: : Deeg HJ, Klingemann HG, Phillips GL, eds. A Guide to Bone Marrow Transplantation, 2nd edn, Berlin: Springer-Verlag, 1992:175-86.
18. Deeg HJ, N Flournoy, KM Sullivan et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 1984;10:957-64.
19. Deeg JH, R Storb, G Longton et al. Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size and fractionation interval on acute and delayed toxicity. Int J Radiat Oncol Biol Phys 1988;15:647-53.
20. Deeg HJ, KM Sullivan, CD Buckner et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986;1:151-7.
21. Dutreix J, E Gluckman, JM Brule. Biological problems of total body irradiation. J Eur Radiother 1982;3:163-73.
22. Evans RG, CL Wheatley, JR Nielsen. Modification of radiation-induced damage to bone marrow stem cells by dose rate, dose fractionation, and prior exposure to Cytoxan as judged by the survival of CFUs: Application to BMT. Int J Radiat Oncol Biol Phys 1988;14:491-5.
23. Ganem G, MF Saint-Marc Girardin, M Kuentz et al. Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988;14:879-84.
24. Gorin NC, P Aegerter, B Auvert et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990;75:1606-14.
25. Kaplan EL, P Meier. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
26. Kim TH, PB McGlave, N Ramsay et al. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Oncol Biol Phys 1990;19:889-97.
27. Kimler BF, CH Park, D Yakar et al. Radiation response of human normal and leukemic hematopoietic cells assayed by in vitro colony formation. Int J Radiat Oncol Biol Phys 1985;11:809-16.
28. Laver J. Radiobiological properties of human hematopoietic and stromal marrow cells. Int J Cell Cloning 1989;7:203-12.
29. Lazarus HM, GB Vogelsang, JM Rowe. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplant 1997;19:577-600.
30. Maraninchi D, JP Vernant, E Gluckman et al. Greffes de moelle allogéniques dans les leucémies aiguës myéloïdes: étude rétrospective chez 111 malades greffés en première rémission complète. Presse Méd 1986;1:2093-96.
31. McDonald GB, P Sharma, DE Matthews et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984;4:116-22.
32. McDonald GB, P Sharma, DE Matthews et al. The clinical coarse of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation 1985;39:603-8.
33. Ozsahin M, Y Belkacémi, F Pène et al. Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. Int J Radiat Oncol Biol Phys 1994;28:343-7.
34. Ozsahin M, Y Belkacémi, F Pène et al. Interstitial pneumonitis following bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. Int J Radiat Oncol Biol Phys 1996;34:71-7.
35. Ozsahin M, F Pène, JM Cosset et al. Morbidity after total body irradiation. Semin Radiat Oncol 1994;4:95-102.
36. Ozsahin M, F Pène, E Touboul et al. Total-body irradiation before bone marrow transplantation: results of two randomized instantaneous dose rates in 157 patients. Cancer 1992;69:2853-65.
37. Ozsahin M, LH Schwartz, F Pène et al. Is body weight a risk factor of interstitial pneumonitis after bone marrow transplantation? Bone Marrow Transplant 1992;10:97.
38. Peto P, MC Pike, P Armitage et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient: Part II. Br J Cancer 1977;35:1-39.
39. Rhee JG, CW Song, TH Kim et al. Effect of fractionation and rate of radiation dose on human leukemic cells, HL-60. Radiat Res 1985; 101:519-27.
40. Ringdén O, I Baryd, B Johansson et al. Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total body irradiation. Acta Radiol Oncol 1983;22:423-8.
41. Ringdén O, T Ruutu, M Remberger et al. A randomized trial comparing busulfan with total-body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 1994;83:2723-30.
42. Ryalls M, HA Spoudeas, PC Hindmarsh et al. Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemia. J Endocrinol 1993;136:331-8.
43. Sanders JE, CD Buckner, D Amos et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988;6:813-8.
44. Scarpati D, F Frassoni, V Vitale et al. Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse. Int J Radiat Oncol Biol Phys 1989;17:547-52.
45. Schmidt GM, JC Niland, SJ Forman et al. Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Transplantation 1993;55:551-7.
46. Shank B. Hyperfractionation versus single dose irradiation in human acute lymphocytic leukemia cells: application to TBI for marrow transplantation. Radiother Oncol 1993;27:30-5.
47. Shank B, FCH Chu, R Dinsmore et al. Hyperfractionated total body irradiation for bone marrow transplantation: results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Pays 1983; 9:1607-11.
48. Shank B, RJ O'Reilly, I Cunningham et al. Total body irradiation for bone marrow transplantation: the Memorial Sloan-Kettering Cancer Center experience. Radiother Oncol Suppl 1990;1:68-71.
49. Sierra J, A Grañena, J García et al. Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients. Bone Marrow Transplant 1993;12:517-23.
50. Song CW, TH Kim, FM Khan et al. Radiobiological basis of total body irradiation with different dose rate and fractionation: repair capacity of hematopoietic cells. Int J Radiat Oncol Biol Phys 1981;7:1695-1701.
51. Sutton L, M Kuentz, C Cordonnier et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation. Bone Marrow Transplant 1993;12:583-9.
52. Tarbell NJ, DA Amato, JD Down et al. Fractionation and dose rate effects in mice: a model for bone marrow transplantation. Int J Radiat Oncol Biol Phys 1987;13:1065-69.
53. Tarbell NJ, EC Guinan, C Niemeyer et al. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1988;15:99-104.
54. Thomas ED. The use and potential of bone marrow allograft and whole-body irradiation in the treatment of leukemia. Cancer 1982;50:1449-54.
55. Thomas ED, RA Clift, J Hersman et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys 1982;8:817-21.
56. Thomas ED, R Storb, CD Buckner. Total body irradiation in preparation for marrow engraftment. Transplant Pros 1976;8:591-3.
57. Tichelli A. Late ocular complications after bone marrow transplantation. Nouv Rev Fr Hematol 1994;36:Suppl 1:S79-82.
58. Travis EL, LJ Peters, J McNeill et al. Effect of dose-rate on total body irradiation: lethality and pathologic findings. Radiother Oncol 1985;4:341-51.
59. Uckun FM, M Chandan-Langlie, W Jaszcz et al. Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia. Cancer Res 1994;53:1431-6.
60. Uckun FM, CW Song. Lack of CD24 antigen expression in B lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts. Blood 1993;81:1323-32.
61. van Os R, H Thames, AWT Konings et al. Radiation-dose fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model. Radiat Res 1993; 136:118-25.
62. Vriesendorp HM. Prediction of effects of therapeutic total body irradiation in man. Radiother Oncol Suppl 1990;1:37-50.
63. Vriesendorp HM. Radiobiological speculations on therapeutic total body irradiation. Crit Rev Oncol Hematol 1990;10:211-24.
64. Wagner JE Jr, GB Voselgang, WE Beschorner. Pathogenesis and pathology of graft vs. host disease. Am J Pediatr Hematol Oncol 1989;11:196-212.
65. Weiner RS, MM Bortin, R P Gale et al. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann Intern Med 1986;104:168-75.
66. Yan R., LJ Peters, EL Travis. Cyclophosphamide 24 hours before or after total body irradiation: effects on lung and bone marrow. Radiother Oncol 1991;21:149-56.